Evaluation of a patient oriented deprescribing strategy to achieve reduction of oversupply of proton pump inhibitors (PPI)

Evaluation of a patient oriented deprescribing strategy to achieve reduction of oversupply of proton pump inhibitors (PPI) - arriba-PPI / arriba-med

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00016364

Enrollment

3060

Registered

2019-01-31

Start date

2018-12-01

Completion date

Unknown

Last updated

2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

medical counseling of patients regarding the reduction of oversupply of proton pump inhibitors (PPI)

Interventions

Group 1: General practitioners and medical assistants are trained in their practices. Training topics are the PPI prescription in general (guideline-conformed indication, dosage and duration of treatm

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: longterm PPI prescription of at least 6 months

Exclusion criteria

Exclusion criteria: reluctance to participate, lack of German fluency, cognitive limitations that hinder study education and comprehension, mere home visit patients (e.g. practice visits are not possible due to frailty)

Design outcomes

Primary

Measure	Time frame
Cumulative DDD-PPI (Defined Daily Doses) per study patient per practice in the following 6 months after first counsel (training of the general practitioner and following counsel with arriba-PPI)	—

Secondary

Measure	Time frame
Cumulative DDD-PPI per study patient per practice in the following 12 months after first counsel (training of the general practitioner and following counsel with arriba-PPI). Ratio of PPI-patients within all patients of one practice for the last two billing quarters at 12 months after training. Average cumulative DDD-PPI within all PPI-patients of one practice for the last two billing quarters at 12 months after training.	—

Measure

Time frame

Cumulative DDD-PPI per study patient per practice in the following 12 months after first counsel (training of the general practitioner and following counsel with arriba-PPI). Ratio of PPI-patients within all patients of one practice for the last two billing quarters at 12 months after training. Average cumulative DDD-PPI within all PPI-patients of one practice for the last two billing quarters at 12 months after training.

—

Countries

Germany

Contacts

Public ContactSabine Quint

Abteilung für Allgemeinmedizin, Präventive und Rehabilitative Medizin, Philipps-Universität Marburg

quints@staff.uni-marburg.de+49-6421-28-25011

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Mar 1, 2026